Cancer News and Research

Latest Cancer News and Research

Patients with high-grade noninvasive bladder cancer do not receive recommended care

A new study has found that almost all patients with high-grade noninvasive bladder cancer do not receive complete care as recommended by current guidelines.

11 Jul 2011

Preliminary results from Generex Oral-lyn clinical trial on type 1 diabetes

Generex Biotechnology Corporation today announced preliminary clinical results of two major trials using the Generex Oral-lyn formulation that will be used for registration and marketing.

11 Jul 2011

QIAGEN to acquire Cellestis

QIAGEN N.V. today announced that it has amended its original proposal to acquire Cellestis Limited, a publicly traded Australian biotechnology company.

From QIAGEN Manchester Limited 11 Jul 2011

Research targets malignant glioma stem cells

Cleveland Clinic researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor.

11 Jul 2011

Scientists discover seven new gene variants that increase risk of prostate cancer

Cancer Research UK-funded scientists have taken a further step to identifying men at a greater risk of prostate cancer with the discovery of seven new variants in the human genome that increase the chances of developing the disease.

11 Jul 2011

Lab grown windpipe saves cancer patient

A team of doctors have replaced the cancer affected windpipe of a patient with an organ made in a lab. This is a medical breakthrough for regenerative medicine. The patient no longer has cancer and is expected to have a normal life expectancy, doctors said.

10 Jul 2011

Circumcision subjected to vote this November in San Francisco

The debate over whether routine circumcision of baby boys being either hygienic, safe or brutal and medically unnecessary continues in San Francisco. This November, residents will vote if the procedure shall be continued.

10 Jul 2011

History of cancer increases risk for developing blood clotting issues following knee arthroscopy

A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure.

8 Jul 2011

Charité-Universitätsmedizin Berlin establishes MagForce NanoTherm therapy center for treatment of tumors

Nanostart subsidiary MagForce Nanotechnologies AG, a leading medical technology company focusing on nanomedicine in oncology, announced that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm therapy center for the treatment of recurrent brain tumors.

8 Jul 2011

Top-line results from HyQ subcutaneous IG phase III study in patients with primary immunodeficiency

Baxter International Inc. and Halozyme Therapeutics, Inc. today announced top-line results of a phase III study of HyQ, an investigational facilitated subcutaneous immune globulin (IG) product for use in patients with primary immunodeficiency (PI).

From Baxter International Inc. 8 Jul 2011

Brigham and Women's Hospital receives NIH Program of Excellence in Glycosciences award

The laboratory of Robert Sackstein, MD, PhD, of the Dermatology Department at Brigham and Women's Hospital (BWH), has been granted a prestigious Program of Excellence Award from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), to support investigations in glycobiology: the discipline which studies how sugars direct biologic processes.

8 Jul 2011

Onconova, SymBio enter commercialization collaboration for rigosertib in Japan and Korea

Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.

8 Jul 2011

Common cell pathway could lead to new treatments for autoimmune diseases and cancer

A discovery by University of Alabama at Birmingham researchers about a how a common cell pathway that helps regulate cell survival and production is turned on could lead to new treatments for autoimmune diseases and cancer.

8 Jul 2011

Blood tests encourage more people to participate in regular screening for colorectal cancer

Epigenomics AG, the cancer molecular diagnostics company, today announced the results of a survey conducted at europacolon's first European CRC Patient Conference, The Power of Patient Voice 2011, showing that patients believe tests using blood samples would encourage more people to participate in regular screening for colorectal cancer.

8 Jul 2011

Scientists discover mechanism that enables developing cancer cells to sustain abnormal growth

Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.

8 Jul 2011

Scientists track public health trends through Twitter

Twitter allows millions of social media fans to comment in 140 characters or less on just about anything: an actor's outlandish behavior, an earthquake's tragic toll or the great taste of a grilled cheese sandwich.

8 Jul 2011

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.

8 Jul 2011

Merck decides not to advance IMO-2055 development for squamous cell carcinoma of the head and neck

Idera Pharmaceuticals today provides an update on the clinical development of IMO-2055 (EMD 1201081), a TLR9 agonist for cancer treatment being developed by Merck KGaA, Darmstadt, Germany, under its collaboration with Idera.

8 Jul 2011

Corporates profit from pinkwashing

Companies that try to increase sales of their products by adopting the color pink and pink ribbons to imply that they support breast cancer research-a practice called pinkwashing-but at the same time permit the use of chemicals shown to cause cancer are committing a form of social injustice against women, according to a thought-provoking article in Environmental Justice.

8 Jul 2011

Pediatricians debunk pearls of medical wisdom

Don't Cross Your Eyes-They'll Get Stuck that Way!, a new book by myth-fighting Indiana University School of Medicine pediatricians Aaron Carroll, M.D., M.S., and Rachel Vreeman, M.D., M.S., debunks the pearls of medical wisdom that many people and even their physicians believe are true. Be prepared to revise your thinking; no, an apple a day won't keep the doctor away and no, warm milk won't help you sleep.

8 Jul 2011

Cancer News and Research

Latest Cancer News and Research

Patients with high-grade noninvasive bladder cancer do not receive recommended care

Preliminary results from Generex Oral-lyn clinical trial on type 1 diabetes

QIAGEN to acquire Cellestis

Research targets malignant glioma stem cells

Scientists discover seven new gene variants that increase risk of prostate cancer

Lab grown windpipe saves cancer patient

Circumcision subjected to vote this November in San Francisco

History of cancer increases risk for developing blood clotting issues following knee arthroscopy

Charité-Universitätsmedizin Berlin establishes MagForce NanoTherm therapy center for treatment of tumors

Top-line results from HyQ subcutaneous IG phase III study in patients with primary immunodeficiency

Brigham and Women's Hospital receives NIH Program of Excellence in Glycosciences award

Onconova, SymBio enter commercialization collaboration for rigosertib in Japan and Korea

Common cell pathway could lead to new treatments for autoimmune diseases and cancer

Blood tests encourage more people to participate in regular screening for colorectal cancer

Scientists discover mechanism that enables developing cancer cells to sustain abnormal growth

Scientists track public health trends through Twitter

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Merck decides not to advance IMO-2055 development for squamous cell carcinoma of the head and neck

Corporates profit from pinkwashing

Pediatricians debunk pearls of medical wisdom

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in